Covered self-expandable metal stents in benign biliary strictures caused by chronic pancreatitis: a randomized controlled trial of 6 versus 12 months of stenting

Abstract Background In chronic pancreatitis (CP), a symptomatic benign biliary stricture (BBS) evolves as an adverse event in 3–30%. Treatment by ERCP with a single plastic biliary stent has been disappointing. Multiple plastic stents are more successful but make the procedure more time consuming than treatment with a fully covered self-expandable metal stent (fcSEMS). The most efficient stenting duration of BBS caused by CP is not known. The aim of this multicenter prospective randomized study was to compare the safety and feasibility of 10 mm diameter fcSEMSs placed for 12 months versus 12 mm diameter fcSEMSs placed for 6 months in the treatment of BBS caused by CP. Methods The patients were randomized into two groups: either 10 mm diameter fcSEMS for 12 months or 12 mm diameter fcSEMS for 6 months. After stent removal, the patients were followed up at 6 and 24 months with liver function tests and abdominal ultrasound. Results A total of 62 consecutive patients undergoing ERCP for the treatment of BBS at six centers were enrolled. Four patients in the 10 mm group and five in the 12 mm group were excluded due to a diagnosis of pancreatic cancer, and two in the 10 mm and four in the 12 mm group were excluded because of death from other causes during the 2-year follow-up. In the 10 mm group, one stent became impacted in the bile duct necessitating hepaticojejunostomy; this patient was also excluded from the final analysis. The final sample size was 24 patients in the 10 mm group and 22 in the 12 mm group. In the 12 mm group, one stent migrated requiring re-stenting. Recurrent strictures occurred in 3 of 24 patients (13%) in the 10 mm group and in 4 of 22 patients (18%) in the 12 mm group ( p = 0.694). Conclusions Both types of fcSEMS are effective in the treatment of BBS secondary to CP. However, the increased risk of pancreatic cancer in these patients should be taken into consideration. Graphical abstract

Authors

Institutions

Publication Details

Journal
Surgical Endoscopy
Published
2026-05-18
DOI
https://doi.org/10.1007/s00464-026-12919-x
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Covered self-expandable metal stents in benign biliary strictures caused by chronic pancreatitis: a randomized controlled trial of 6 versus 12 months of stenting

Marianne Udd, Heikki Karjula, Truls Hauge, Outi Lindström et al.
Surgical Endoscopy
Gallbladder and Bile Duct Disorders
article

Covered self-expandable metal stents in benign biliary strictures caused by chronic pancreatitis: a randomized controlled trial of 6 versus 12 months of stenting

Marianne Udd, Heikki Karjula, Truls Hauge, Outi Lindström, Jevgeni Sumerin, Juha Grönroos, Tuomo Rantanen, Leena Kylänpää
article en

Abstract

Abstract Background In chronic pancreatitis (CP), a symptomatic benign biliary stricture (BBS) evolves as an adverse event in 3–30%. Treatment by ERCP with a single plastic biliary stent has been disappointing. Multiple plastic stents are more successful but make the procedure more time consuming than treatment with a fully covered self-expandable metal stent (fcSEMS). The most efficient stenting duration of BBS caused by CP is not known. The aim of this multicenter prospective randomized study was to compare the safety and feasibility of 10 mm diameter fcSEMSs placed for 12 months versus 12 mm diameter fcSEMSs placed for 6 months in the treatment of BBS caused by CP. Methods The patients were randomized into two groups: either 10 mm diameter fcSEMS for 12 months or 12 mm diameter fcSEMS for 6 months. After stent removal, the patients were followed up at 6 and 24 months with liver function tests and abdominal ultrasound. Results A total of 62 consecutive patients undergoing ERCP for the treatment of BBS at six centers were enrolled. Four patients in the 10 mm group and five in the 12 mm group were excluded due to a diagnosis of pancreatic cancer, and two in the 10 mm and four in the 12 mm group were excluded because of death from other causes during the 2-year follow-up. In the 10 mm group, one stent became impacted in the bile duct necessitating hepaticojejunostomy; this patient was also excluded from the final analysis. The final sample size was 24 patients in the 10 mm group and 22 in the 12 mm group. In the 12 mm group, one stent migrated requiring re-stenting. Recurrent strictures occurred in 3 of 24 patients (13%) in the 10 mm group and in 4 of 22 patients (18%) in the 12 mm group ( p = 0.694). Conclusions Both types of fcSEMS are effective in the treatment of BBS secondary to CP. However, the increased risk of pancreatic cancer in these patients should be taken into consideration. Graphical abstract

Surgical Endoscopy
Oslo University Hospital (NO), University of Helsinki (FI), University of Eastern Finland (FI), Oulu University Hospital (FI), Helsinki University Hospital (FI), Turku University Hospital (FI), Kuopio University Hospital (FI), South Karelia Central Hospital (FI), Etelä-Karjalan sosiaali ja terveyspiiri (FI)
Helsingin Yliopisto, Helsingin ja Uudenmaan Sairaanhoitopiiri
Good health and well-being
Openalex Percentile: Top 9%
Gallbladder and Bile Duct Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.